Back to search

Article

Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES Trial

2026-03-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> In patients with atrial fibrillation (AF) and stable coronary artery disease beyond 1 year after percutaneous coronary intervention (PCI), oral anticoagulant monotherapy is guideline-recommended; however, its efficacy and safety in patients with complex PCI remain uncertain. <h4>Methods</h4> We conducted a post-hoc analysis of the randomized ADAPT AF-DES trial comparing NOA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6d0d50d-7236-5adb-8b4c-27e257319442
DOI
10.64898/2026.02.26.26347227
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES TrialDOI 10.64898/2026.02.26.26347227
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity
Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSemantic proximity
Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Anti-coagulant in Atrial FibrillationSemantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity
Coronary Embolism in Atrial Fibrillation: A Distinct High-Risk Phenotype With Residual Thromboembolic Risk Despite Anticoagulation.Semantic proximity
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary SyndromeSemantic proximity
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks.Semantic proximity
Contemporary burden of atrial fibrillation in mechanical thrombectomy stroke patients in the United StatesSemantic proximity
Antithrombotic Therapy in Patients Undergoing Transcatheter Aortic Valve ImplantationSemantic proximity
Dual antiplatelet therapy in patients with coronary artery disease after percutaneous coronary intervention with drug-eluting stents: A systematic review and network meta-analysisSemantic proximity
Select a neighboring publication to make it the new centre.